Identification of an immunotherapy-responsive molecular subtype of bladder cancer

por Song, Bic-Na, Kim, Seon-Kyu, Mun, Jeong-Yeon, Choi, Young-Deuk, Leem, Sun-Hee, Chu, In-Sun
Publicado en EBioMedicine (2019)

Genomic Signature of the Standardized Uptake Value in (18)F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer

por Kim, Seon-Kyu, Ahn, Sung Gwe, Mun, Jeong-Yeon, Jeong, Mi-So, Bae, Soong June, Lee, Ju-Seog, Jeong, Joon, Leem, Sun-Hee, Chu, In-Sun
Publicado en Cancers (Basel) (2020)

VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer

por Kim, Min-Hye, Yang, Gi-Eun, Jeong, Mi-So, Mun, Jeong-Yeon, Lee, Sang-Yeop, Nam, Jong-Kil, Choi, Yung Hyun, Kim, Tae Nam, Leem, Sun-Hee
Publicado en BMC Med Genomics (2021)

Fanconi Anemia Pathway Activation by FOXM1 is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance

por Roh, Yun-Gil, Mun, Jeong-Yeon, Kim, Seon-Kyu, Park, Won Young, Jeong, Mi-So, Kim, Tae Nam, Kim, Won-Tae, Choi, Yung Hyun, Chu, In-Sun, Leem, Sun-Hee
Publicado en Cancers (Basel) (2020)

Thymoquinone-Induced Tristetraprolin Inhibits Tumor Growth and Metastasis through Destabilization of MUC4 mRNA

por Lee, Se-Ra, Mun, Jeong-Yeon, Jeong, Mi-So, Lee, Hyun-Hee, Roh, Yun-Gil, Kim, Won-Tae, Kim, Min-Hye, Heo, Jeonghoon, Choi, Yung Hyun, Kim, Su Jin, Cha, Hee-Jae, Jun, Mira, Leem, Sun-Hee
Publicado en Int J Mol Sci (2019)

E2F1 Promotes Progression of Bladder Cancer by Modulating RAD54L Involved in Homologous Recombination Repair

por Mun, Jeong-Yeon, Baek, Seung-Woo, Park, Won Young, Kim, Won-Tae, Kim, Seon-Kyu, Roh, Yun-Gil, Jeong, Mi-So, Yang, Gi-Eun, Lee, Jong-Ho, Chung, Jin Woong, Choi, Yung Hyun, Chu, In-Sun, Leem, Sun-Hee
Publicado en Int J Mol Sci (2020)